Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India Read more
Roche gets EUA in India for antibody cocktail (Casirivimab and Imdevimab) to treat COVID-19 Read more
Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData Read more
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and New Zealand Read more